Acute coronary syndromes: 6c-Patients discharged on lipid-lowering therapy
Identifying and definitional attributes
|Metadata item type:||Indicator|
|Short name:||Indicator 6c-Patients discharged on lipid-lowering therapy|
|Registration status:||Health, Standard 12/09/2016|
Proportion of patients with a final diagnosis of acute coronary syndrome (ACS) who are prescribed lipid-lowering therapy at separation from hospital.
Lowering lipid levels (using statins) is an effective primary and secondary prevention treatment for vascular events, including stroke (Amarenco et al. 2006).
|Indicator set:||Clinical care standard indicators: acute coronary syndromes Health, Standard 12/09/2016|
|Outcome area:||Individualised care plan Health, Standard 12/09/2016|
Collection and usage attributes
Both the numerator and the denominator include patients with acute chest pain, or other symptoms suggestive of ACS.
The denominator excludes statin-intolerant ACS patients, and other ACS patients for whom statins or other lipid-lowering therapies are contraindicated and for whom the contraindication is documented. Contraindications for statins may include advance care directives, being on a palliative care pathway, and clinical judgement, subject to discussion with patients, family and carers.
Presented as a percentage.
(Numerator ÷ denominator) x 100
Number of patients with a final diagnosis of ACS who are prescribed a statin or other lipid-lowering therapy at separation from hospital.
Number of patients with a final diagnosis of ACS who are separated from hospital.
|Unit of measure:||Episode|
Source and reference attributes
Australian Commission on Safety and Quality in Health Care
Amarenco P et al. 2006. High-dose atorvastatin after stroke or transient ischemic attack. New England Journal of Medicine 355(6):549–559.